Chemoinformaics analysis of Aristololactam-glucoside
| Molecular Weight | 455.419 | nRot | 3 |
| Heavy Atom Molecular Weight | 434.251 | nRig | 30 |
| Exact Molecular Weight | 455.122 | nRing | 6 |
| Solubility: LogS | -4.542 | nHRing | 3 |
| Solubility: LogP | 1.038 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 3 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 16 |
| nHA | 9 | APOL | 60.7307 |
| nHD | 4 | BPOL | 30.5893 |
| QED | 0.416 |
| Synth | 4.137 |
| Natural Product Likeliness | 1.312 |
| NR-PPAR-gamma | 0.792 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.415 |
| HIA | 0.163 |
| CACO-2 | -5.324 |
| MDCK | 0.0000321 |
| BBB | 0.151 |
| PPB | 0.832456 |
| VDSS | 1.024 |
| FU | 0.159277 |
| CYP1A2-inh | 0.059 |
| CYP1A2-sub | 0.673 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.836 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.537 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.111 |
| CL | 2.322 |
| T12 | 0.224 |
| hERG | 0.004 |
| Ames | 0.645 |
| ROA | 0.029 |
| SkinSen | 0.075 |
| Carcinogencity | 0.923 |
| EI | 0.008 |
| Respiratory | 0.056 |
| NR-Aromatase | 0.565 |
| Antiviral | Yes |
| Prediction | 0.746193 |